Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Price Movement Clarification

Cohance Lifesciences Price Movement Clarification

Cohance Lifesciences Limited clarified that the recent increase in share trading volume is purely market-driven and attributable to prevailing conditions. The company confirmed there is no pending undisclosed price-sensitive information. All regulatory disclosures under SEBI Listing Regulations are up to date, ensuring transparency for investors regarding the scrip's behavior.

Source

NSE filing, NSE: COHANCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Cohance Lifesciences Ltd: key numbers

Share price
₹480.00
Market cap
₹18,365 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
172.9×Sector 46.1×
Promoter holding
57.48%-0.01% QoQ
FII holding
7.71%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Cohance Lifesciences Ltd

All →

Other price movement clarification announcements

All →